If you're seeing this message, that means JavaScript has been disabled on your browser , pleaseenable JS to make this app work. Get Updates
812 Followers on Owler
4DMT Funding History Since 4DMT was founded in 2013, it has participated in 8 rounds of funding. In total 4DMT has raised $517.8M. 4DMT's last funding round was on May 2023 for a total of $138.0M. 4DMT Funding Rounds Post-IPO Equity
May 2023
$138M
__
Series C
Jun 2020
$75M
15
Viking Global Investors ,
Amzak Health ,
Casdin Capital ,
Cystic Fibrosis Foundation ,
Longevity Vision Fund ,
MiraeAsset Financial Group ,
Octagon Investments ,
QUAD Investment Management ,
Arrowmark Partners ,
Berkeley Catalyst Fund ,
BVF Partners L.P. ,
Pappas Capital ,
Chiesi Ventures ,
Perceptive Advisors ,
Ridgeback Capital Investments Series B
Aug 2018
$90M
11
Viking Global Investors ,
ArrowMark Partners ,
Janus Henderson Investors ,
The Biotechnology Value Fund ,
Mirae Asset Financial Group ,
Pappas Capital ,
Chiesi Ventures ,
Perceptive Advisors ,
Ridgeback Capital Investments ,
Biotechnology Value Fund ,
CureDuchenne Ventures 4DMT Investors Series C, Series B
Jun 2020, Aug 2018
4DMT has 22 investors, including Viking Global Investors, Amzak Health and Casdin Capital. The latest investment occurred in May 2023.